Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Acta Anaesthesiol Scand ; 58(5): 508-24, 2014 May.
Article in English | MEDLINE | ID: mdl-24593804

ABSTRACT

Safe and reliable venous access is mandatory in modern health care, but central venous catheters (CVCs) are associated with significant morbidity and mortality, This paper describes current Swedish guidelines for clinical management of CVCs The guidelines supply updated recommendations that may be useful in other countries as well. Literature retrieval in the Cochrane and Pubmed databases, of papers written in English or Swedish and pertaining to CVC management, was done by members of a task force of the Swedish Society of Anaesthesiology and Intensive Care Medicine. Consensus meetings were held throughout the review process to allow all parts of the guidelines to be embraced by all contributors. All of the content was carefully scored according to criteria by the Oxford Centre for Evidence-Based Medicine. We aimed at producing useful and reliable guidelines on bleeding diathesis, vascular approach, ultrasonic guidance, catheter tip positioning, prevention and management of associated trauma and infection, and specific training and follow-up. A structured patient history focused on bleeding should be taken prior to insertion of a CVCs. The right internal jugular vein should primarily be chosen for insertion of a wide-bore CVC. Catheter tip positioning in the right atrium or lower third of the superior caval vein should be verified for long-term use. Ultrasonic guidance should be used for catheterisation by the internal jugular or femoral veins and may also be used for insertion via the subclavian veins or the veins of the upper limb. The operator inserting a CVC should wear cap, mask, and sterile gown and gloves. For long-term intravenous access, tunnelled CVC or subcutaneous venous ports are preferred. Intravenous position of the catheter tip should be verified by clinical or radiological methods after insertion and before each use. Simulator-assisted training of CVC insertion should precede bedside training in patients. Units inserting and managing CVC should have quality assertion programmes for implementation and follow-up of routines, teaching, training and clinical outcome. Clinical guidelines on a wide range of relevant topics have been introduced, based on extensive literature retrieval, to facilitate effective and safe management of CVCs.


Subject(s)
Catheterization, Central Venous/standards , Anti-Bacterial Agents/therapeutic use , Arrhythmias, Cardiac/etiology , Catheter-Related Infections/etiology , Catheter-Related Infections/prevention & control , Catheterization, Central Venous/adverse effects , Catheterization, Central Venous/methods , Embolism, Air/etiology , Embolism, Air/prevention & control , Equipment Failure , Fluoroscopy , Health Personnel/education , Hemorrhagic Disorders/diagnosis , Humans , Infection Control/methods , Infection Control/standards , Manikins , Patient Positioning , Pneumothorax/diagnostic imaging , Pneumothorax/etiology , Pneumothorax/prevention & control , Thrombolytic Therapy/standards , Ultrasonography, Interventional , Vascular Access Devices , Venous Thrombosis/drug therapy , Venous Thrombosis/etiology , Venous Thrombosis/prevention & control
2.
Acta Physiol (Oxf) ; 195(4): 495-502, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18826500

ABSTRACT

AIM: Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator. We hypothesized that those piglets exposed to prolonged iNO react with a modified renal function. METHODS: Randomized, placebo-controlled exposure to 40 p.p.m. iNO (30 h) in piglets (n = 20). Plasma and urine were sampled during three periods (first and second 12 h periods, and finally a 6 h period). We measured urine volumes, plasma and urine electrolytes (UNa, UK, UCl), plasma creatinine and urea. We calculated creatinine clearance (Ccr), and fractional excretions of sodium and potassium (FENa, FEK) and urinary excretions of electrolytes (UENa, UEK, UECl). Haemodynamic data were recorded and renal tubular apoptosis detected. RESULTS: For the first 12 h, certain parameters significantly increased in the iNO group (mean +/- SD): UNa (mmol L(-1)), 87.7 (+/-35.0) vs. 39.3 (+/-22.9), UCl (mmol L(-1)) 80.4 (+/-32.8) vs. 48.0 (+/-26.7), FENa (%) 2.1 (+/-0.8) vs. 0.7 (+/-0.5), FEK (%) 31.7 (+/-7.0) vs. 20.7 (+/-12.3), as well as UENa (mmol) 61.0 (+/-21.1) vs. 27.6 (+/-17.9) and UECl (mmol) 57.3 (24.5) vs. 37.6 (29.0). These changes were absent in the second and third periods of the study. Significant differences in percentage of apoptotic cell nuclei in the renal cortex and medulla were found after iNO exposure: 39% vs. 15%. CONCLUSION: Exposure to 40 p.p.m. iNO in healthy anaesthetized piglets has a transient natriuretic effect that disappears after 12 h. We also found evidence of renal tubular apoptosis promotion after 30 h of iNO.


Subject(s)
Apoptosis/drug effects , Kidney Tubules/drug effects , Kidney Tubules/physiology , Nitric Oxide/administration & dosage , Administration, Inhalation , Animals , Cell Nucleus/physiology , Chlorides/urine , Drug Administration Schedule , Kidney Cortex/physiology , Kidney Medulla/physiology , Natriuresis/drug effects , Nitric Oxide/adverse effects , Potassium/urine , Swine , Time Factors
3.
Acta Anaesthesiol Scand ; 49(1): 110-2, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15675995

ABSTRACT

A 22-year-old male was admitted to hospital with diarrhea and vomiting, cardiac arrhythmias, severe hypokalemia and gradual onset of muscular weakness. A potassium infusion was started, but for several hours serum potassium remained low. Evidence of toxic ingestion was initially lacking. When it became clear -- after a considerable delay -- that the patient had ingested barium nitrate, hemodialysis was started. This resulted in rapid clinical improvement with correction of hypokalemia and restored muscular function. Intoxication with barium causes hypokalemia, arrhythmias, muscular weakness and paralysis, often requiring respiratory support. This patient presented with symptoms typical of severe barium intoxication, non-responsive to potassium supplementation. There are few published reports on the use of hemodialysis in barium poisoning. This case confirms the possible benefit of hemodialysis in severe cases, where potassium supplementation alone is insufficient.


Subject(s)
Barium Compounds/poisoning , Nitrates/poisoning , Renal Dialysis , Adult , Arrhythmias, Cardiac/chemically induced , Arrhythmias, Cardiac/drug therapy , Barium/blood , Brain Damage, Chronic/chemically induced , Brain Damage, Chronic/psychology , Critical Care , Cyanides/poisoning , Electrocardiography , Humans , Hypokalemia/chemically induced , Hypokalemia/drug therapy , Male , Muscle Weakness/chemically induced , Muscle Weakness/drug therapy , Potassium/blood , Potassium/therapeutic use , Suicide, Attempted
4.
Paediatr Anaesth ; 12(6): 530-6, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12139595

ABSTRACT

BACKGROUND: Nitric oxide (NO), when inhaled, has a synergistic effect with airway recruitment strategies such as positive endexpiratory pressure (PEEP) or continuous positive airway pressure (CPAP) in improving oxygenation in lung injury. METHODS: We modified a commercially available nasal CPAP (nCPAP) system to enable the concomitant delivery of inhaled NO (iNO) and nCPAP to neonates and term babies. Oxygen, NO and nitrogen dioxide (NO2) concentrations were measured, comparing the effects of using 50 or 1000 parts per million (p.p.m.) NO stock gas cylinders. RESULTS: Stable and accurate delivery of iNO was found for both stock gas concentrations. Using a 50 p.p.m. NO stock gas resulted in limited NO2 formation, with a maximum inspired NO2 concentration of < or = 0.3 p.p.m. (dose range up to 37 p.p.m. iNO), which was interpreted as the result of progressive dilution with nitrogen. In contrast, using a 1000 p.p.m. NO stock gas cylinder, inspired NO2 levels increased nonlinearly as expected with an increasing inspired concentration of NO. CONCLUSIONS: Inhaled NO can be safely and reliably delivered by the system we describe. The NO2 levels generated by the system are low, at least up to a dose of 37 p.p.m. NO, regardless of a stock gas concentration of 50 or 1000 p.p.m. NO. Using a 50 p.p.m. NO stock gas concentration, up to 80% oxygen can be given at 10 p.p.m. iNO.


Subject(s)
Nitric Oxide/administration & dosage , Positive-Pressure Respiration/instrumentation , Administration, Inhalation , Humans , Infant , Infant, Newborn , Nitric Oxide/therapeutic use
5.
J Consult Clin Psychol ; 69(5): 814-24, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11680558

ABSTRACT

Sixty children, ages 7-17 years, who fulfilled Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994) diagnosis for various specific phobias were randomized to (a) 1-session exposure treatment alone, (b) 1-session treatment with a parent present, or (c) wait-list control group for 4 weeks. After the waiting period, the wait-list patients were rerandomized to the active treatments. The patients' phobias were assessed with behavioral approach tests (approach behavior, experienced anxiety, and physiological reactions), whereas general anxiety, depression, phobic tendencies, and anxiety sensitivity were assessed with self-report inventories. Assessments were done pre-, post-, and 1-year following treatment. Results showed that both treatment conditions did significantly better than the control condition, whereas the treatment groups did equally well on most measures, and the effects were maintained at follow-up. The implications of these results are discussed.


Subject(s)
Behavior Therapy/statistics & numerical data , Phobic Disorders/therapy , Adolescent , Child , Female , Humans , Male , Treatment Outcome
6.
Intensive Care Med ; 26(2): 229-38, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10784315

ABSTRACT

OBJECTIVE: To evaluate the efficacy of surfactant and inhaled nitric oxide (iNO) in endotoxin-induced acute lung injury (ALI). DESIGN: Prospective, randomised, controlled experimental study. SETTING: A medical university hospital research laboratory. INTERVENTION: Twenty-nine adult rabbits (2.4-3.4 kg) were given two doses of intravenous endotoxin (Escherichia coli) (0.01 mg/kg and, 12 h later, 0.1 mg/kg), and then subjected to mechanical ventilation. After 8 h these animals were allocated to four treatment groups: (1) control, (2) iNO at 20 ppm (NO), (3) surfactant at 100 mg/kg (Surf) and (4) both surfactant and iNO as in groups 2 and 3 (SNO), and ventilated for a further 6 h followed by broncho-alveolar lavage (BAL), analysis of surfactant contents in BAL fluid and histological examination of the lungs. MEASUREMENTS AND RESULTS: All the animals had developed ALI with respiratory failure 8 h after the second dose of endotoxin as evidenced by a decrease of PaO2/FIO2 from 520 +/- 30 to 395 +/- 19 mmHg and dynamic compliance (Cdyn) from 1.20 +/- 0.11 to 0.73 +/- 0.05 ml/ cmH2O x kg, and an increase of intrapulmonary shunting (Qs/Qt) from 7.5 +/- 0.8% to 12.9 +/- 1.0% (all measurements p < 0.01 versus baseline). In the SNO group, values for PaO2/FIO2, Cdyn and Qs/Qt after 6 h were 301 +/- 15 mmHg, 0.67 +/- 0.05 ml/cmH2O x kg and 16.5 +/- 0.8%, compared to 224 +/- 26 mmHg, 0.53 +/- 0.04 ml/ cmH2O x kg and 24.1 +/- 2.0%, respectively, in the control group (all measurements p < 0.01). Both Surf and NO groups showed intermediate levels of these parameters. In both Surf and SNO groups, the minimum surface tension of BAL fluid was lower, and the content of disaturated phosphatidylcholine/total protein higher, than in the control and NO groups (p < 0.01). Histological features of lung injury were less prominent and wet/dry lung weight ratio lower in the NO, Surf and SNO groups. Decreased surfactant protein A (SP-A) and its mRNA expression were found in all endotoxin-exposed groups, but the SP-A content of the SNO group was moderately improved in comparison to the control group. Surfactant aggregate size was not affected. CONCLUSION: Early application of surfactant and iNO moderately mitigated ALI as reflected by improvement of lung mechanics, pulmonary perfusion and morphology.


Subject(s)
Bronchodilator Agents/pharmacology , Nitric Oxide/pharmacology , Pulmonary Surfactants/pharmacology , Respiratory Insufficiency/drug therapy , Respiratory Insufficiency/physiopathology , Administration, Inhalation , Analysis of Variance , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchodilator Agents/administration & dosage , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Endotoxins , Lung Injury , Nitric Oxide/administration & dosage , Organ Size , Prospective Studies , Pulmonary Surfactants/administration & dosage , Rabbits , Random Allocation , Respiration, Artificial , Respiratory Function Tests , Statistics, Nonparametric
7.
Biol Neonate ; 76(6): 374-82, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10567766

ABSTRACT

AIM: To evaluate effects of inhaled nitric oxide (iNO) in experimental meconium aspiration treated with high-frequency (HFV) or conventional mechanical ventilation (CMV). Ventilated adult rabbits had meconium instilled intratracheally resulting in respiratory failure as evidenced by more than 50% reduction of dynamic lung compliance (Cdyn) and increase in mean oxygenation index (OI) from 1 to 16. The animals were then allocated to 2 groups treated without (control) or with iNO at 20 ppm (NO). In each group the animals were initially ventilated with CMV or HFV mode for 3 h and then in a crossover fashion with HFV or CMV for another 3 h (CMV-->HFV, HFV-->CMV), respectively. In the first 3 h of treatment, the animals subjected to HFV-CMV in the control, and those with both HFV-CMV and CMV-HFV in the NO group had significantly reduced OI. In the subsequent 3 h, the animals in the control group with CMV-HFV did not improve in OI and those with HFV-CMV had deteriorated. In the NO group with both CMV-HFV and HFV-CMV moderate improvement of OI was observed. Platelet aggregation capability and counts were significantly decreased and bleeding time prolonged in animals receiving iNO treatment. These results suggest that both HFV alone and a combined treatment of iNO with either CMV or HFV are more effective in improving blood oxygenation than that of CMV in this animal model. The influence of iNO on platelet aggregation should be considered.


Subject(s)
High-Frequency Ventilation , Meconium Aspiration Syndrome/therapy , Nitric Oxide/administration & dosage , Administration, Inhalation , Animals , Humans , Infant, Newborn , Platelet Aggregation , Rabbits
8.
Zhongguo Yao Li Xue Bao ; 20(8): 691-5, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10678099

ABSTRACT

AIM: To compare effects of pulmonary surfactant and inhaled nitric oxide (iNO) in improvement of survival and blood oxygenation in ventilated rabbits with acute hypoxic respiratory failure induced by repeated bronchoalveolar lavage (BAL). METHODS: After BAL all the rabbits had more than 50% reduction of dynamic lung compliance (Cdya), 50% increment of resistance of respiratory system (Rrs), and an increase of mean oxygenation index (OI) from 1 to 22. The rabbits were then randomly allocated to groups receiving (1) mechanical ventilation only (Control), (2) iNO 0.8 mumol.L-1 (20 ppm) (NO), (3) intratracheal bolus surfactant phospholipids at 100 mg.kg-1 (Surf), and (4) combined surfactant at 100 mg.kg-1 with inhaled NO at 0.8 mumol.L-1 (Surf + NO). All the rabbits were ventilated with standardized tidal volume (8-10 mL.kg-1) for another 8 h or until early death. RESULTS: The rabbits in both control and NO groups had the lowest survival rate, deterioration of lung mechanics and OI, whereas those in the Surf and Surf + NO groups had modestly improved Cdyn, Rrs, and OI. Only rabbits in the Surf + NO group had significantly improved survival rate and alveolar expansion. CONCLUSION: Surfactant with or without iNO is more effective compared to the control and iNO groups in rabbit, suggesting that iNO is not effective unless a method to recruit alveoli is applied.


Subject(s)
Nitric Oxide/pharmacology , Pulmonary Surfactants/pharmacology , Respiratory Distress Syndrome/physiopathology , Airway Resistance , Animals , Bronchoalveolar Lavage , Drug Synergism , Lung Compliance/drug effects , Oxygen/metabolism , Rabbits , Respiratory Distress Syndrome/etiology
9.
Am J Respir Crit Care Med ; 158(2): 437-43, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9700118

ABSTRACT

Intratracheal administration of surfactant and inhaled nitric oxide (INO) have had variable effects in clinical trials on patients with acute respiratory distress syndrome (ARDS). We hypothesized that combined treatment with exogenous surfactant and INO may have effects in experimental ARDS. After intravenous infusion of oleic acid in adult rabbits and 4-6 h of ventilation, there was more than a 40% reduction in both dynamic compliance (Cdyn) of the respiratory system and functional residual capacity (FRC), a 50% increment of respiratory resistance (Rrs), a 70% reduction in PaO2 /FIO2, and an increase in intrapulmonary shunting (Q S/Q T) from 4.4 to 33.5%. The animals were then allocated to groups receiving (1) neither surfactant nor INO (control), (2) 100 mg/kg of surfactant (S) administered intratracheally, (3) 20 ppm INO (NO), or (4) 100 mg/kg of surfactant and 20 ppm INO (SNO), and subsequently ventilated for 6 h. After the period of ventilation, the animal lungs were used for analysis of disaturated phosphatidylcholine (DSPC) and total proteins (TP) in bronchoalveolar lavage fluid (BALF), and for determination of alveolar volume density (VV). The animals in the control group had the lowest survival rate, and no improvement in lung mechanics and blood oxygenation, whereas those in the S group had a modest but statistically significant improvement in Cdyn, Rrs, PaO2 and FRC, reduced Q S/Q T, lowered minimum surface tension (gammamin) of BALF, and increased DSPC/ TP and alveolar VV. The NO group had increased PaO2 and reduced Q S/Q T. The SNO group showed improved Cdyn, Rrs, FRC, DSPC/TP, alveolar VV, and gammamin of BALF comparable to the S group, but there was a further increase in survival rate and PaO2, and additional reduction in Q S/Q T and TP in BALF. These results indicate that, in this animal model of ARDS, a combination of surfactant therapy and INO is more effective than either treatment alone.


Subject(s)
Nitric Oxide/administration & dosage , Pulmonary Surfactants/administration & dosage , Respiratory Distress Syndrome/drug therapy , Administration, Inhalation , Animals , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Nitric Oxide/therapeutic use , Oleic Acid , Organ Size , Pulmonary Surfactants/therapeutic use , Rabbits , Respiratory Distress Syndrome/chemically induced , Respiratory Distress Syndrome/physiopathology , Respiratory Function Tests
10.
Eur J Surg ; 164(1): 13-6, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9537703

ABSTRACT

OBJECTIVES: To compare a forced air warming system with passive measures to avoid perioperative hypothermia. DESIGN: Prospective open study. SETTING: University hospital, Sweden. SUBJECTS: 28 Patients scheduled for extensive thoracoabdominal operations under standard combined general and regional anaesthesia. MAIN OUTCOME MEASURES: Temperature measured before, repeatedly under anaesthesia and during the operation for up to three hours, and then up to eight hours postoperatively. RESULTS: Three patients were excluded. In the 12 patients who had forced air warming, temperature was preserved, and ranged from a mean (SD) of 36.8 (0.7) degrees C, (95% confidence interval (CI) 36.4 to 37.2) at the start to 36.9 (0.8) degrees C, (95% CI 36.5 to 37.3) after 3 hours. In patients who had conservative passive heat preservation techniques the mean temperature fell significantly perioperatively, from 36.8 (0.6) degrees C (95% CI 36.5 to 37.1) at the start to 35.1 (0.5) degrees C, (95% CI 34.9 to 35.3), after three hours of anaesthesia and surgery. This was a significant fall compared with the temperature in the study group (p < 0.001). CONCLUSION: Forced air warming intraoperatively can preserve normothermia during extensive thoracoabdominal operations.


Subject(s)
Body Temperature , Heating/methods , Hypothermia/prevention & control , Intraoperative Care , Intraoperative Complications/prevention & control , Aged , Elective Surgical Procedures , Esophageal Neoplasms/surgery , Humans , Hypothermia/etiology , Intraoperative Care/methods , Middle Aged , Prospective Studies , Rectal Neoplasms/surgery , Urinary Bladder Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...